Endophthalmitis Caused by Corynebacterium Species

Clinical Features, Antibiotic Susceptibility, and Treatment Outcomes

Ajay E. Kuriyan, Jayanth Sridhar, Harry W Flynn, Laura C. Huang, Nicolas A. Yannuzzi, William E Smiddy, Janet L Davis, Thomas A Albini, Audina Berrocal, Darlene Miller

Research output: Contribution to journalArticle

Abstract

Purpose To report the clinical features, antibiotic susceptibility profiles, treatment, and visual acuity (VA) outcomes of endophthalmitis caused by Corynebacterium species. Design Retrospective case series. Participants Patients with endophthalmitis caused by Corynebacterium species. Methods Microbiology database records were retrospectively reviewed for all patients with endophthalmitis caused by Corynebacterium species from January 1, 1990, to December 31, 2012, at a large university referral center. The corresponding clinical records were then reviewed to evaluate endophthalmitis clinical features and treatment outcomes. Main Outcome Measures Presenting clinical features, visual acuity outcomes, and antibiotic susceptibility patterns. Results For the 10 patients identified, clinical settings included post–cataract surgery (n = 6), post–penetrating keratoplasty (n = 2), and posttrabeculectomy (n = 2). The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range: 1 day to 28 months). All isolates were susceptible to vancomycin. Presenting VA ranged from 7/200 to no light perception. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n = 5) and pars plana vitrectomy with intravitreal antibiotic injection (n = 5). VA outcomes were ≥20/60 in 5 of 10 patients (50%) and ≤20/400 in 5 of 10 patients (50%). Conclusions The most common clinical setting was post–cataract surgery. All isolates were susceptible to vancomycin. Despite prompt treatment with appropriate antibiotics, visual outcomes varied.

Original languageEnglish (US)
Pages (from-to)200-205
Number of pages6
JournalOphthalmology Retina
Volume1
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Corynebacterium
Endophthalmitis
Visual Acuity
Anti-Bacterial Agents
Intravitreal Injections
Vancomycin
Corneal Transplantation
Temazepam
Vitrectomy
Microbiology
Therapeutics
Referral and Consultation
Outcome Assessment (Health Care)
Databases
Light

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Endophthalmitis Caused by Corynebacterium Species : Clinical Features, Antibiotic Susceptibility, and Treatment Outcomes. / Kuriyan, Ajay E.; Sridhar, Jayanth; Flynn, Harry W; Huang, Laura C.; Yannuzzi, Nicolas A.; Smiddy, William E; Davis, Janet L; Albini, Thomas A; Berrocal, Audina; Miller, Darlene.

In: Ophthalmology Retina, Vol. 1, No. 3, 01.05.2017, p. 200-205.

Research output: Contribution to journalArticle

@article{96d34cf195ee405d8064baf7d304e480,
title = "Endophthalmitis Caused by Corynebacterium Species: Clinical Features, Antibiotic Susceptibility, and Treatment Outcomes",
abstract = "Purpose To report the clinical features, antibiotic susceptibility profiles, treatment, and visual acuity (VA) outcomes of endophthalmitis caused by Corynebacterium species. Design Retrospective case series. Participants Patients with endophthalmitis caused by Corynebacterium species. Methods Microbiology database records were retrospectively reviewed for all patients with endophthalmitis caused by Corynebacterium species from January 1, 1990, to December 31, 2012, at a large university referral center. The corresponding clinical records were then reviewed to evaluate endophthalmitis clinical features and treatment outcomes. Main Outcome Measures Presenting clinical features, visual acuity outcomes, and antibiotic susceptibility patterns. Results For the 10 patients identified, clinical settings included post–cataract surgery (n = 6), post–penetrating keratoplasty (n = 2), and posttrabeculectomy (n = 2). The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range: 1 day to 28 months). All isolates were susceptible to vancomycin. Presenting VA ranged from 7/200 to no light perception. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n = 5) and pars plana vitrectomy with intravitreal antibiotic injection (n = 5). VA outcomes were ≥20/60 in 5 of 10 patients (50{\%}) and ≤20/400 in 5 of 10 patients (50{\%}). Conclusions The most common clinical setting was post–cataract surgery. All isolates were susceptible to vancomycin. Despite prompt treatment with appropriate antibiotics, visual outcomes varied.",
author = "Kuriyan, {Ajay E.} and Jayanth Sridhar and Flynn, {Harry W} and Huang, {Laura C.} and Yannuzzi, {Nicolas A.} and Smiddy, {William E} and Davis, {Janet L} and Albini, {Thomas A} and Audina Berrocal and Darlene Miller",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.oret.2016.11.007",
language = "English (US)",
volume = "1",
pages = "200--205",
journal = "Ophthalmology Retina",
issn = "2468-7219",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Endophthalmitis Caused by Corynebacterium Species

T2 - Clinical Features, Antibiotic Susceptibility, and Treatment Outcomes

AU - Kuriyan, Ajay E.

AU - Sridhar, Jayanth

AU - Flynn, Harry W

AU - Huang, Laura C.

AU - Yannuzzi, Nicolas A.

AU - Smiddy, William E

AU - Davis, Janet L

AU - Albini, Thomas A

AU - Berrocal, Audina

AU - Miller, Darlene

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Purpose To report the clinical features, antibiotic susceptibility profiles, treatment, and visual acuity (VA) outcomes of endophthalmitis caused by Corynebacterium species. Design Retrospective case series. Participants Patients with endophthalmitis caused by Corynebacterium species. Methods Microbiology database records were retrospectively reviewed for all patients with endophthalmitis caused by Corynebacterium species from January 1, 1990, to December 31, 2012, at a large university referral center. The corresponding clinical records were then reviewed to evaluate endophthalmitis clinical features and treatment outcomes. Main Outcome Measures Presenting clinical features, visual acuity outcomes, and antibiotic susceptibility patterns. Results For the 10 patients identified, clinical settings included post–cataract surgery (n = 6), post–penetrating keratoplasty (n = 2), and posttrabeculectomy (n = 2). The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range: 1 day to 28 months). All isolates were susceptible to vancomycin. Presenting VA ranged from 7/200 to no light perception. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n = 5) and pars plana vitrectomy with intravitreal antibiotic injection (n = 5). VA outcomes were ≥20/60 in 5 of 10 patients (50%) and ≤20/400 in 5 of 10 patients (50%). Conclusions The most common clinical setting was post–cataract surgery. All isolates were susceptible to vancomycin. Despite prompt treatment with appropriate antibiotics, visual outcomes varied.

AB - Purpose To report the clinical features, antibiotic susceptibility profiles, treatment, and visual acuity (VA) outcomes of endophthalmitis caused by Corynebacterium species. Design Retrospective case series. Participants Patients with endophthalmitis caused by Corynebacterium species. Methods Microbiology database records were retrospectively reviewed for all patients with endophthalmitis caused by Corynebacterium species from January 1, 1990, to December 31, 2012, at a large university referral center. The corresponding clinical records were then reviewed to evaluate endophthalmitis clinical features and treatment outcomes. Main Outcome Measures Presenting clinical features, visual acuity outcomes, and antibiotic susceptibility patterns. Results For the 10 patients identified, clinical settings included post–cataract surgery (n = 6), post–penetrating keratoplasty (n = 2), and posttrabeculectomy (n = 2). The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range: 1 day to 28 months). All isolates were susceptible to vancomycin. Presenting VA ranged from 7/200 to no light perception. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n = 5) and pars plana vitrectomy with intravitreal antibiotic injection (n = 5). VA outcomes were ≥20/60 in 5 of 10 patients (50%) and ≤20/400 in 5 of 10 patients (50%). Conclusions The most common clinical setting was post–cataract surgery. All isolates were susceptible to vancomycin. Despite prompt treatment with appropriate antibiotics, visual outcomes varied.

UR - http://www.scopus.com/inward/record.url?scp=85070485262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070485262&partnerID=8YFLogxK

U2 - 10.1016/j.oret.2016.11.007

DO - 10.1016/j.oret.2016.11.007

M3 - Article

VL - 1

SP - 200

EP - 205

JO - Ophthalmology Retina

JF - Ophthalmology Retina

SN - 2468-7219

IS - 3

ER -